There were no significant differences in AT8, AT180, or PHF1-positive pathological tau nor changes in total tau levels assessed by Tau5 indicating that Qβ-AT8 vaccination failed to reduce tau pathology in the rTg4510 model of tauopathy but also did not alter total tau levels (Fig 3d–e). The gene discussed is MAPT; the disease is tauopathy.